Part D Rx Use Shows “Little Change” As Enrollees Enter Coverage Gap, CMS Says
This article was originally published in The Pink Sheet Daily
CMS gives first glimpse at the kind of Part D drug claims data that will become available to researchers in December.
You may also be interested in...
Twenty-three percent of a large sample of Medicare Part D enrollees taking oral drugs for diabetes changed their medication use when they reached the gap in coverage, according to a study released by the Kaiser Family Foundation Aug. 21
CMS is targeting Dec. 1 as the date for opening Medicare Part D drug claims data to both government and independent researchers
New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.